Global Addiction Treatment Market: Snapshot
With the increasing number of smokers and drug addicts across the world, the global market for addiction treatment is witnessing tremendous rise. The scenario is likely to remain so in the near future with the augmenting abuse of prescription drugs. The rising support of governments in various economies in increasing the awareness pertaining to drug addiction and implementation of favorable reimbursement policies are also expected to boost this market in the years to come. In 2016, the market presented an opportunity worth US$4.33 bn. Proliferating at a CAGR of 6.60% between 2017 and 2025, it is likely to rise to US$7.70 bn by 2025 end.
Tobacco/Nicotine Addiction Treatment to Report Strong Demand
Predominantly, the global addiction treatment market is analyzed on the basis of the type of the treatment, type of the drug, treatment center, distribution channel, and the geography. Based on the type of the treatment, the market is segmented into tobacco/nicotine addiction treatment, alcohol addiction treatment, opioid addiction treatment, and several other substance addiction treatment. Tobacco/nicotine addiction treatment solutions are registering a greater demand than other treatments and the trend is expected to continue in the years to come.
In terms of the type of the drug, the market is classified into bupropion, acamprosate, varenicline, disulfiram, methadone, naltrexone, buprenorphine, and nicotine replacement products. Among these, the demand for nicotine replacement products is higher and is projected to remain so over the next few years.
Based on the treatment center, the market is bifurcated into outpatient treatment centers, residential treatment centers, and inpatient treatment centers. By distribution channel, the market is divided into hospital pharmacy and medical stores.
North America to Retain Leadership
In terms of the geography, the worldwide addiction treatment market is spread across Europe, Asia Pacific, North America, the Middle East and Africa, and Latin America. Among these, the North America market holds the leading position and is projected to remain there in the years to come. However, it is Asia Pacific, which is likely to offer the most promising growth the market players in the years to come.
The rising awareness about drug addiction and its negative impacts, favorable reimbursement policies for addiction treatment, and the high disposable income of consumers are likely to support the North America market for addiction treatment over the next few years. Asia Pacific, on the other hands, is anticipated to be driven by the rising prevalence of drug addiction, increasing number of tobacco consumers, mushrooming rehabilitation centers, and a surge in various government health programs aimed at increasing awareness regarding addiction. The improvement in the healthcare infrastructure is also predicted to boost the Asia Pacific market for addiction treatment in the near future.
At the forefront of the global market for addiction treatment are Cipla Ltd., Allergan plc, Alkermes plc, Pfizer Inc., Orexo AB, GlaxoSmithKiline plc, Purdue Pharma L.P, Mallinckrodt, and Reckitt Benckiser. The market demonstrates a consolidated landscape and is expected to remain intensely competitive in the years to come.
Global Addiction Treatment Market: Overview
This report on the addiction treatment market analyzes the current and future scenario of the global market. Awareness initiatives by different drug manufacturers, government bodies and growing abuse of prescription drugs are the major drivers of the global addiction treatment market during the forecast period.
The global addiction treatment market report comprises a detailed elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the country’s market with respect to the segments based on treatment type, drug type, treatment centers, and distribution channels. An elaborated qualitative analysis of drivers and trends has been provided in the market overview section. This section also provides market attractiveness analysis in terms of country, thus presenting a thorough analysis of the overall competitive scenario in the global addiction treatment market.
Global Addiction Treatment Market: Segmentation
Based on treatment centers, the global addiction treatment market is classified into alcohol addiction treatment, tobacco/nicotine addiction treatment, opioid addiction treatment and other substance addiction treatment. The market segments have been analyzed based on awareness of addiction treatment, actual percentage accessing different insurance policies for treatment, and medical scenarios. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGR for the forecast period from 2017 to 2025, considering 2016 as the base year.
Based on drug type, the market has been segmented into bupropion, varenicline, acamprosate, disulfiram, naltrexone, methadone, buprenorphine, nicotine replacement products and others. In term of treatment centers, the market has been segmented into outpatient treatment centers, residential treatment centers, and inpatient treatment centers. Based on distribution channels, the addiction treatment market segmented into hospital pharmacy, medical stores and others. The distribution channels segmentation has been analyzed on the basis of purchase of drugs which is prescribed for addiction treatment.
The market segments have been extensively analyzed based on drugs and products used in the treatment of addiction, centers that have been widely used for treatment and medical reimbursements. The market size and forecast in terms of value (US$ Mn) for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Addiction Treatment Market: Regional Analysis
Geographically, the global addiction treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
The report also profiles major players in the global addiction treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments.
The key players operating in the global addiction treatment market are Cipla Ltd., Allergan plc, Alkermes plc, Pfizer Inc., Orexo AB, GlaxoSmithKiline plc, Purdue Pharma L.P, Mallinckrodt, and Reckitt Benckiser (Indivior PLC) among others.
The global addiction treatment market is segmented as follows:
By Treatment Type
- Alcohol Addiction Treatment
- Tobacco/Nicotine Addiction Treatment
- Opioid Addiction Treatment
- Other Substance Addiction Treatment
By Drug Type
- Nicotine replacement products
- Others surgical
By Treatment Centers
- Outpatient Treatment Centers
- Residential Treatment Centers
- Inpatient Treatment Centers
By Distribution Channels
- Hospital pharmacy
- Medical stores
- North America
- Rest of Europe
- Asia Pacific (APAC)
- Australia & New Zealand
- Rest of APAC
- Latin America (LATAM)
- Rest of LATAM
- Middle East & Africa (MEA)
- South Africa
- GCC Countries
- Rest of MEA